PHARMACOLOGY

Pharmacology Track Faculty

 

William Clarke, Ph.D.

William Clarke, Ph.D.

serotonin, opioids, estrogen, G protein coupled receptors, schizophrenia, depression, anxiety, pain, functional selectivity, constitutive receptor activity, receptor theory

J. Thomas Cunningham, Ph.D.

J. Thomas Cunningham, Ph.D.

vasopressin, supraoptic nucleus, sympathetic nervous system, hypertension, hyponatremia, angiotensin, thirst, sodium appetite

Lynette C. Daws, Ph.D.

Lynette C. Daws, Ph.D.

serotonin transporter, dopamine transporter, depression, stress, drug abuse, in vivo chronoamperometry

 

Franco B. Folli, M.D., Ph.D.

Franco B. Folli, M.D., Ph.D.

 molecular mechanisms of insulin resistance, Islets' of Langerhans amyloidosis, obesity, type 2 diabetes and insulin resistance syndrome, bariatric surgery

Charles France, Ph.D.

Charles France, Ph.D.

drug abuse, opioids, benzodiazepines, GHB, drug discrimination, self administration, dependence, withdrawal, neuropharmacology

Alan Frazer, Ph.D.

Alan Frazer, Ph.D.

antidepressants, norepinephrine, serotonin, transporters, vagal nerve stimulation

 

Lisa R. Gerak, Ph.D.

Lisa R. Gerak, Ph.D.

benzodiazepines, neuroactive steroids, drug discrimination, dependence, withdrawal

Andrea Giuffrida, Ph.D.

Andrea Giuffrida, Ph.D.

cannabinoid, anandamide, dopamine, Parkinson disease, schizophrenia, dyskinesias

 

Julie Hensler, Ph.D.

Julie Hensler, Ph.D.

serotonin, brain derived neurotrophic factor (BDNF), depression, anxiety, behavior, stress

 

Nathaniel Jeske, Ph.D.

Nathaniel Jeske, Ph.D.

pain, TRPV1, AKAP, inflammation, ECM

Wouter Koek, Ph.D.

Wouter Koek, Ph.D.

 drug abuse, alcohol, GHB, prescription drugs, drug discovery, antidepressants, behavioral pharmacology, drug discrimination

Yui-Wing Francis Lam

Yui-Wing Francis Lam, Pharm.D.

drug metabolism, clinical pharmacology, pharmacokinetics, pharmacogenetics

 

Senlin Li, M.D.

Senlin Li, M.D.

Parkinson's disease, neurodegenerative diseases, stem cell, iPS, hematopoietic stem cell, stem cell therapy, gene therapy, altherosclerosis

Feng Liu, Ph.D.

Feng Liu, Ph.D.

adiponectin, insulin, obesity, diabetes, glucose, glycogen synthesis, insulin signal transduction, insulin resistance, aging, neuronal insulin signaling

Xin-Yun Lu, Ph.D.

Xin-Yun Lu, Ph.D.

adiponectin, obesity, eating disorders, depression, melancortin system, adiposity hormone, leptin

 

Richard F. Ludueña, Ph.D.

Richard F. Ludueña, Ph.D.

structure of tubulin, biochemistry of microtubules, tubulin isotypes, mechanism of action of anti-tumor drugs

Lance McMahon, Ph.D.

Lance McMahon, Ph.D.

drug dependence, cannabinoids, nicotine, opiods, sedative-hypnotics, behavior

Susan Mooberry, Ph.D.

Susan Mooberry, Ph.D.

drug discovery, breast cancer, anti-mitotic agents, natural products

David Morilak, Ph.D.

David Morilak, Ph.D.

antidepressants, anxiety, behavior, cognition, depression, HPA axis, in situ hybridization, microdialysis, norepinephrine, PTSD, stress

 

Thomas J. Slaga, Ph.D.

Thomas J. Slaga, Ph.D.

glucocorticoid hormones, carcinogen, carcinogenesis, tumor, papillomas, squamous cell carcinomas, skin cancer

J. Randy Strong, Ph.D.

J. Randy Strong, Ph.D.

receptor mechanisms, tyrosine hydroxylase, hypertension, depression, Parkinson's disease, aging, dopamine neurons, Rapamycin

LuZhe Sun

LuZhe Sun, Ph.D.

cell signaling, cancer biology, experimental therapy